CHRNA4 and myasthenia gravis: Thus, in the present study, we developed a new methodology that employed a single cell manipulation system called MAGrahd [27,28] coupled with novel high-throughput cell-based binding assays to analyze several hundred single peripheral B cells and the Abs they produce, as well as their nAChR-antigen specificities and possible pathogenic roles in human MG.